We are live on
!
Find out more
Invesco Pharmaceuticals ETF
PJP
PJP
97 hedge funds and large institutions have $66M invested in Invesco Pharmaceuticals ETF in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 29 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
9% more funds holding
Funds holding: 89 → 97 (+8)
4% more capital invested
Capital invested by funds: $63.6M → $66M (+$2.39M)
0.13% less ownership
Funds ownership: 23.13% → 23% (-0.13%)
31% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 29
Holders
97
Holders Change
+8
Holders Change %
+8.99%
% of All Funds
1.39%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
20
Reduced
29
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Jane Street
New York
|
+$1.14M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$960K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$561K |
| 4 |
HAS
HBW Advisory Services
Simi Valley,
California
|
+$501K |
| 5 |
AWA
Arete Wealth Advisors
Chicago,
Illinois
|
+$395K |
Top Sellers
| 1 |
DBIA
Dumont & Blake Investment Advisors
Princeton,
New Jersey
|
-$1.71M |
| 2 |
Morgan Stanley
New York
|
-$1.03M |
| 3 |
Goldman Sachs
New York
|
-$701K |
| 4 |
Focus Partners Wealth
Boston,
Massachusetts
|
-$506K |
| 5 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
-$390K |
